REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT

.

Source: Expert Opinion on Biological Therapy - April 28, 2023 Category: Drugs & Pharmacology Authors: Raveendra KR Chirag Rathod Rahul Darnule Subramanian Loganathan Sarika Deodhar Radhika A Ashwani Marwah Nitin M Chaudhari Binay K Thakur Sivakumar Vaidyanathan Sandeep Nilkanth Athalye Source Type: research